Insider · CIK 0001463321

Mahony Susan

Reports to the SEC for 6 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001463321

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$246.18	−$73.9K	829
2026-06-09	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$237.21	−$71.2K	1,129
2026-06-08	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,429 sh	—	—	1,429
2026-06-08	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,429 sh	—	—	0
2026-06-05	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,721 sh	—	—	1,721
2026-06-04	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2026-01-12	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.5K sh	—	—	11,500
2026-01-12	ZYMEZymeworks Inc. · Restricted Stock UnitA Award	Director	AAward	+7,700 sh	—	—	7,700
2025-06-06	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,166 sh	—	—	3,166
2025-06-06	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,429 sh	—	—	1,429
2025-06-05	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2025-02-21	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,312 sh	—	—	1,312
2024-12-10	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,000
2024-06-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,799 sh	—	—	5,799
2024-05-29	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+2,750 sh	—	—	2,750
2024-02-27	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+191 sh	—	—	191
2023-12-07	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37K sh	—	—	37,000
2023-10-10	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,502 sh	—	—	1,502
2023-10-10	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,873 sh	—	—	5,873
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−9,345 sh	$116.50	−$1.09M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−9,306 sh	$116.50	−$1.08M	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-07-27	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,016 sh	—	—	4,016
2023-05-25	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2023-04-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+3,913 sh	—	—	3,913
2023-04-28	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,879 sh	$111.16	−$209K	2,034
2023-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,913 sh	—	—	0
2022-12-21	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-25	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-04-29	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+4,223 sh	—	—	18,275
2022-04-29	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−1,658 sh	$98.56	−$163K	16,617
2022-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,223 sh	—	—	0
2022-04-28	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+3,913 sh	—	—	3,913
2021-05-20	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-05-06	Zymeworks BC Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-04-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	—	—	18,409
2021-04-30	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,357 sh	$94.62	−$412K	14,052
2021-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	0
2021-04-29	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+4,223 sh	—	—	4,223
2020-06-11	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-05-08	Zymeworks BC Inc.Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2020-05-02	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+12K sh	—	—	12,036
2020-05-02	Horizon Therapeutics Public Ltd CoF Tax Payment	Director	FTax Payment	−4,725 sh	$35.62	−$168K	7,311
2020-05-02	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2020-04-30	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+11.1K sh	—	—	11,098
2019-08-01	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsA Award	Director	AAward	+12K sh	—	—	12,036
2019-05-17	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-30	ASMBASSEMBLY BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2018-04-16	LLYELI LILLY & CoS Sale	SVP & Pres., Lilly Oncology	SSale	−17.4K sh	$80.08	−$1.39M	40,685
2018-04-16	LLYELI LILLY & CoS Sale	SVP & Pres., Lilly Oncology	SSale	−17.4K sh	$80.08	−$1.39M	28,273

Recent filings

Accepted (ET)
Jun 104
Mahony Susan0001193125-26-266435
SEC(opens sec.gov)
Jun 94
Mahony Susan0001193125-26-264040
SEC(opens sec.gov)
Jun 54
Mahony Susan0001193125-26-259822
SEC(opens sec.gov)
Jan 124
Mahony Susan0001193125-26-010843
SEC(opens sec.gov)
Jun 104
Mahony Susan0000950170-25-084554
SEC(opens sec.gov)
Jun 94
Mahony Susan0000950170-25-083703
SEC(opens sec.gov)
Feb 254
Mahony Susan0000950170-25-027090
SEC(opens sec.gov)
Dec 124
Mahony Susan0000950170-24-135921
SEC(opens sec.gov)
Jun 114
Mahony Susan0000950170-24-071965
SEC(opens sec.gov)
May 304
Mahony Susan0000950170-24-066604
SEC(opens sec.gov)
Feb 294
Mahony Susan0000950170-24-023351
SEC(opens sec.gov)
Dec 84
Mahony Susan0000950170-23-069112
SEC(opens sec.gov)
Oct 124
Mahony Susan0001209191-23-052736
SEC(opens sec.gov)
Oct 64
Mahony Susan0001209191-23-052375
SEC(opens sec.gov)

Companies

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007